Alnylam Pharmaceuticals, Inc. (0HD2)
LSE
Real-time Data
07:00 AM
Day's Range
217.1852 wk Range
199.81Overview - 0HD2 - Alnylam Pharmaceuticals, Inc.
Key Statistics
Valuation
Enterprise Value
33.47B
P/E (Trailing)
‪8.77‬
Price / Sales (TTM)
‪0.0044‬
Price / Book
‪24.90‬
EV / EBITDA
‪31.74‬
Profitability
Gross Margin
‪54.26%‬
Profit Margin
‪16.12%‬
Operating Margin
‪17.92%‬
Return on Assets
‪12.34%‬
Return on Equity
‪96.55%‬
Ownership
Shares Outstanding
101.03M
Float
133.23M
Held by Insiders
‪0.18%‬
Held by Institutions
‪101.66%‬
Price stats
Beta
‪0.30‬
50-Day Avg
‪170.73‬
200-Day Avg
‪180.79‬
Market Cap - 0HD2 - Alnylam Pharmaceuticals, Inc.
Peers - 0HD2 - Alnylam Pharmaceuticals, Inc.
Peer Comparison
Compared with companies in Biotechnology listed on LSE.
- 0HD2LSEAlnylam Pharmaceuticals, Inc.25.47BMarket Cap-77.57%52-week change8.78P/E (Trailing)‪16.12%‬Profit Margin
- 0MGBLSEGenmab A/S198.39BMarket Cap+15.12%52-week change33.69P/E (Trailing)‪29.01%‬Profit Margin
- 0QZULSEVertex Pharmaceuticals Incorporated Common Stock128.96BMarket Cap+20.00%52-week change0.53P/E (Trailing)‪34.99%‬Profit Margin
- 0A45LSEModerna Inc.95.05BMarket Cap+87.31%52-week change72.95P/E (Trailing)‪11.32%‬Profit Margin
- 0R2MLSERegeneron Pharmaceuticals, Inc.79.08BMarket Cap+20.99%52-week change0.11P/E (Trailing)‪27.86%‬Profit Margin
- 0QW0LSEargenx SE49.68BMarket Cap+27.60%52-week change40.07P/E (Trailing)‪-47.51%‬Profit Margin
- 0NZTLSEUCB SA41.70BMarket Cap-23.88%52-week change120.47P/E (Trailing)‪6.45%‬Profit Margin
Profile Summary - 0HD2 - Alnylam Pharmaceuticals, Inc.
About
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on RNA interference therapeutics. Alnylam Pharmaceuticals develops, manufactures, and commercializes medicines designed to silence disease-causing genes, with a primary emphasis on rare genetic and cardiometabolic conditions. Its current portfolio…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
